An updated review of the effects of eicosapentaenoic acid- and docosahexaenoic acid-derived resolvins on bone preservation

Prostaglandins Other Lipid Mediat. 2022 Jun:160:106630. doi: 10.1016/j.prostaglandins.2022.106630. Epub 2022 Mar 6.

Abstract

Resolvins are biosynthesized from omega-3 eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) in vivo by means of enzymatic activities, and these factors can attenuate inflammation and promote tissue regeneration. Inflammatory bone disorders can lead to bone loss and thereby be harmful to human health. The link between bone preservation and resolvins has been discussed in some experimental studies. Significant evidence has shown that resolvins benefit bone health and bone preservation by promoting the resolution of inflammation and directly regulating osteoclasts and osteoblasts. Therefore, this review highlights the role and beneficial impact of resolvins derived from EPA and DHA on inflammatory bone disorders, such as rheumatoid arthritis and periodontitis. In addition, the mechanisms by which resolvins exert their beneficial effects on bone preservation have also been summarized based on the available literature.

Keywords: Bone preservation; Inflammatory bone disorder; Resolvins.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Arthritis, Rheumatoid*
  • Docosahexaenoic Acids / pharmacology
  • Eicosapentaenoic Acid* / pharmacology
  • Fatty Acids
  • Humans
  • Inflammation

Substances

  • Fatty Acids
  • Docosahexaenoic Acids
  • Eicosapentaenoic Acid